Pall Corporation has announced the opening of a $2 million Nanyang Polytechnic (NYP) Centre of Excellence in biologics manufacturing featuring various Pall Biotech technologies for practical training and application.
On January 4th, Pall hosted official opening ceremonies to celebrate the role that the NYP Centre of Excellence will play in the evolution of this rapidly growing industry. Annually, the training Centre will introduce 300 NYP School of Chemical and Life Sciences students to the latest technologies and advances in the industry.
In its debut year, the NYP Centre of Excellence is showcasing single-use technologies, including chromatography column packing and filter integrity testing apparatus supplied by Pall Biotech. Each technology enables more thorough purification of substances in both biopharmaceutical and biologics processes, and helps students see the value of integrity in process.
“Large molecule drugs offer the potential to treat debilitating and life-threatening diseases in ways that were not possible before. Yet, to achieve this, manufacturing processes need to evolve for greater speed, reduced cost, and higher quality outputs,” said Steve Waters, Vice-President of Biotechnologies, Pall Biotech Asia. “The NYP Centre will benefit students and the wider Biotech industry through direct access to the latest technologies. Overall, the goal is to increase workforce skill levels in Singapore and its neighboring countries.”